This project will support the Climate Adaptation and Resilience (CLARE2) partnership by covering the operational costs (including salaries and benefits), office expenses and travel of project-paid positions required to implement the program.
Artificial intelligence (AI) solutions and data science approaches are increasingly being used to identify risks, conduct predictive modeling and provide evidence-based recommendations for public health policy and action.
The newly released annual report on the Global Partnership for Education (GPE) Knowledge and Innovation Exchange (KIX) shows that the initiative — the largest education fund of its kind — is closing the gap between research innovation and policy impact.
IDRC, the Israel Science Foundation, the Azrieli Foundation and the Canadian Institutes of Health Research (CIHR) are pleased to announce the second research competition under Phase II of the Joint Canada-Israel Health Research Program.
The Canadian Institutes of Health Research (CIHR) and IDRC, on behalf of the Government of Canada, are supporting a rapid research response to outbreaks of Monkeypox in Canada and Africa. The Monkeypox Rapid Research Response competition will launch the week of August 1, 2022.
This project will support Phase II of the Knowledge for Democracy Myanmar (K4DM2) partnership by covering the operational costs of capacity building, including salaries and benefits, office costs and travel of IDRC staff.
IDRC and the Minister of International Development, the Honourable Harjit Sajjan, are pleased to announce that Dr. Dorothy Nyambi has been appointed as Chairperson of IDRC’s Board of Governors, Nurjehan Mawani has been appointed as governor and Gilles Rivard, Purnima Mane and Akwasi Aidoo have been reappointed as governors.
Lakes provide essential natural resources for populations in low- and middle-income countries (LMICs), but there is growing concern of contamination with antimicrobial resistant (AMR) determinants from animal and human sources, especially beta-lactams and carbapenems that are the cornerstone of human antimicrobial therapy.
More than half of the world’s population is excluded from opportunities the rule of law provides, and 1.5 billion people cannot access support to resolve justice problems. IDRC supports research on legal empowerment strategies to address this growing justice gap and to promote vibrant civic spaces.
Zulfiqar A. Bhutta, a long-time IDRC grantee, has been awarded the John Dirks Canada Gairdner 2022 Global Health Award “for the development and evaluation of evidence-based interventions in child and maternal health for marginalized populations, focusing on outcomes for the ‘first thousand days’ of life.”
For many people, the raison d’être of global health is the achievement of health equity for all people worldwide. Reaffirming this view is the United Nations’ Sustainable Development Goal 3, which seeks to “ensure healthy lives and promote well-being for all at all ages.” Yet, after decades of programming and billions of dollars invested in global health, alarming health inequities persist across and within countries. The current COVID-19 pandemic has further exacerbated these health inequities, underscoring the need for the field of global health to do more and to do better.
Colistin is considered a last-resort antimicrobial for treatment of infections with multidrug-resistant bacteria, classified by the World Health Organization (WHO) as ‘highest prioritized, critically important for human medicine’.